MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
Inserm · Délégation Paris 7 · +5 more institutions
Abstract
UNLABELLED: Molecular classifications defining new tumor subtypes have been recently refined with genetic and transcriptomic analyses of benign and malignant hepatocellular tumors. Here, we performed microRNA (miRNA) profiling in two series of fully annotated liver tumors to uncover associations between oncogene/tumor suppressor mutations and clinical and pathological features. Expression levels of 250 miRNAs in 46 benign and malignant hepatocellular tumors were compared to those of 4 normal liver samples with quantitative reverse-transcriptase polymerase chain reaction. miRNAs associated with genetic and clinical characteristics were validated in a second series of 43 liver tumor samples and 16 nontumor…
Citation impact
- FWCI
- 22.69
- Percentile
- 100%
- References
- 31
Authors
7- YLYannick Ladeiro
Inserm, Délégation Paris 7, Université Paris Cité, Génomique Fonctionnelle des Tumeurs Solides
- GCGabrielle Couchy
Inserm, Délégation Paris 7, Université Paris Cité, Génomique Fonctionnelle des Tumeurs Solides
- CBCharles Balabaud
Inserm, Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André
- PBPaulette Bioulac‐Sage
Inserm, Centre Hospitalier Universitaire de Bordeaux, Hôpital Pellegrin
- LPLaura Pelletier
Inserm, Délégation Paris 7, Université Paris Cité, Génomique Fonctionnelle des Tumeurs Solides
Topics & keywords
- microRNA
- Oncogene
- Hepatocellular carcinoma
- Cancer research
- Gene expression profiling
- Hepatitis B virus
- Hepatocellular adenoma
- Biology
- Good health and well-being